Impact of liver cancer

Liver cancer is the fastest growing cause of cancer-related deaths in Australia – yet there is so little research and so little is known about its prevalence, detection or treatment in Australia.

As the peak body for liver cancer, the Liver Foundation, commissioned a study by Deloitte into the social and economic cost of primary liver cancer in Australia – as a piece of foundational evidence to turn around the discussions for government funding support and to raise public awareness of the disease.

Finding that liver cancer cost Australia $4.8 billion in 2019-20, that the cost to the country’s health system per person with liver cancer is one of the highest of all diseases, and that liver cancer is over-represented in Aboriginal and Torres Strait Islander people; the report laid the foundations for a credible government and public relations exercise.

H/Advisors firstly assisted with public awareness, securing a total of 61 media items about the Deloitte Report across TV, radio, print and online channels, reaching 2.58 million Australians.

The Liver Foundation has also engaged H/Advisors to undertake Government Relations work advocating for financial investment to continue to increase awareness and education around early detection and prevention of liver disease and less invasive screening.